A Study of LY3192767 in Healthy Participants

NCT03025009 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3192767
DRUG: Basal Insulin Peglispro
DRUG: Insulin Glargine
DRUG: Placebo

Sponsor

Eli Lilly and Company